chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ringing in her ears; received the Pfizer vaccine/first dose of the Moderna Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in her ears) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the Pfizer vaccine/first dose of the Moderna Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 22-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TINNITUS (Ringing in her ears) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the Pfizer vaccine/first dose of the Moderna Covid-19). At the time of the report, TINNITUS (Ringing in her ears) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the Pfizer vaccine/first dose of the Moderna Covid-19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. No treatment medication were reported.
pt recvd vax 27JAN93 & w/in 24 hrs an enlarging, erythematous ring began appearing; seen by MD 1FEB93 reaction size 5 1/2 x 4 1/2 cm; no pruritus;
Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, ARTHRALGIA (Joint pain) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Non significant follow up received on 19-MAY-2021, no new information
patient had received a first dose of G9, he missed the scheduled time for his second dose.; No additional AE details; This spontaneous report was received from a pharmacist via a company Representative referring to a 43 years old male patient. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.     On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route, lot number and expiration date were not reported) for prophylaxis. The patient missed the scheduled time for his second dose (inappropriate schedule of product administration). No additional adverse event (AE) details or product quality complaint (PQC).
Expired Drug Used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 6-month-old female patient who received HBV (Engerix B pediatric) (batch number lp724, expiry date 18-MAY-2023) for prophylaxis.   On 30-JUN-2023, the patient received Engerix B pediatric (intramuscular, rt. vastus lateralis) .5 ml. On 30-JUN-2023, an unknown time after receiving Engerix B pediatric, the patient experienced expired vaccine used (Verbatim: Expired Drug Used). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-JUL-2023 The reporter gave permission for GSK to contact her. The reporter consented to follow up. The patient received an expired Engerix-B, which led to expired vaccine used.
full blown episode of chicken pox occurred 24-30 hrs p/vax; spoke w/CDC who felt unlikely to be  covered by shot this soon;
Extreme fatigue and brain fog. Extremely tired since the vaccine. Never feel rested even after 8 hours of sleep. Become exhausted and fall asleep most days in the middle of the day. Also have difficulty remembering common words, and am forgetful. This is all new since the vaccine. I thought it was initially just a side effect, but it has not gotten any better 6 months later.  I had a routine physical with labs completed in March, and all came back within normal limits.
10 y.o. female with PMHx of mild intermittent asthma and chronic constipation, presenting with vaginal ulcers accompanied by dysuria x1 day PTA, lower abdominal discomfort most likely secondary to chronic constipation, and fever and bandemia that have resolved since admission. Cause of vaginal ulcers and pain are continuing to be worked up with wide differential, with consults from gynecology and dermatology. Genecology workup was urgent priority to determine possibility of abuse, and have so far resulted negative for syphilis, HIV, HSV1/2 and VZV. GC/Chlamydia is still pending. Wound and urine cutlers are NGTD. RVP of swabbed ulcers is negative. Currently, there is lower suspicion of infectious origin due to negative results to date. Social work and child protection also following patient.  Of note, this patient received her COVID-19 vaccine shortly prior to presentation of fever and vaginal ulcers. A case report shown Lipschütz ulcer development in a 12 year old girl following COVID-19 vaccination, with more reports of patients developing Lipschütz ulcers following COVID-19 infection. Patient is COVID-negative as of 2/5/22.   Other potential causes of patient's current symptoms include vaginal foreign body, Crohn's, EBV- related Lipschütz ulcer, Behcet syndrome, and contact irritation from change in laundry detergent. There was concern for vaginal foreign body due to vaginal discharge and patient endorsing pain in the vagina, but internal pain is more likely secondary to chronic constipation x7 days. Patient will receive enema today and continue bowel regimen, will observe for symptom resolution. Internal vaginal exam deferred for now due to need for general anesthesia, gynecology will follow up. Foreign body is lower on differential as this would not explain vaginal ulcers. Crohn's can be associated with constipations, abdominal discomfort, and vaginal ulcers, so fecal calprotectin was sent. Awaiting EBV results as well.
flushed; elbow hip pain covid; elbow hip pain covid; appearing toes red swollen painful; appearing toes red swollen painful; appearing toes red swollen painful; elbow hip pain covid; This is a spontaneous report from a contactable other hcp (patient). A 77-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: el3247), via an unspecified route of administration in arm left on 19Jan2021 at 08:30 AM as single dose for COVID-19 immunisation. Medical history included htn (hypertension). Patient had allergy from Indocin. Concomitant medication included (other medications the patient received within 2 weeks of vaccination) lisinopril (LISINOPRIL). The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Jan2021 at 08:30, the patient experienced flushed, elbow hip pain covid appearing toes red swollen painful still on day 8. The events were considered as non-serious. Patient reported no for seriousness criteria-results in death, seriousness criteria-life threatening, seriousness criteria-caused/prolonged hospitalization, seriousness criteria-disabling/incapacitating and seriousness criteria-congenital anomaly/birth defect. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Treatment was received for the adverse event (home care). The outcome of the events was reported as not recovered.  Follow-up attempts are completed. No further information is expected.
I tested positive for COVID-19 on March 23, 2023, My symptoms were sore throat, cough, headache, fever, and body aches. I was taking Dayquil, and Benzonatate for my for symptoms.
Hot raised, super red itchy, burning rash. Using Benadryl and Motrin. Im 3 days into the rash and it has doubled in size.
Initial report received from a healthcare professional who is also patient, on 05 September 2012. A female patient whose age, medical history and concomitant medications were not reported had received a dose of FLUZONE intradermal injection (lot number UT4163AA, anatomical site of administration was not reported) on an unspecified date. The patient reported that she received the FLUZONE ID shot last season and she received a red mark on her arm which was lasted for 03 weeks, she also experienced induration on an unspecified date. She also stated that she didn't tolerate it well and it got hurt while it was being administered. Corrective treatment and laboratory investigation were not reported. The patient's outcome was not reported. Documents held by sender: None.
All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days). On 30-Dec-2021, EXPIRED PRODUCT ADMINISTERED (All patients received Expired Moderna COVID-19 vaccine from a vial that was stored in the refrigerator beyond 30 days) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.  Patient had not reported side effects so far.
Area of erythema and induration 1 1/2 inches x 2 1/4 inches. Complained of pain at area. No drainage. Treated with Keflex and cool compresses.
PATIENT STATED FEELING EXHAUSTED TWO DAYS AFTER THE SECOND SHOT OF MODERNA. ADDITIONALLY, SHE REPORTED OF HAVING LOW GRADE FEVER (98-99 F). TOOK TYLENOL AND REPORTED OF FEELING A LITTLE BIT BETTER. DENIES SHORTNESS OF BREATH, CHEST PAIN, NAUSEA NOR VOMITTING.
Client states reaction started about 48 hours post vaccine. It started out with redness and itchyness at site where shot was given and a very bad migraine headache with much fatigue. The redness and itchiness turned into swelling at the site the following day. The swelling continues throughout the weekend post vaccine. The swelling got to the bigger than the size of a golf ball, very red, and warm to the touch. The fatigue has continued and client is still reporting much tiredness, which is not her usual. Arm is still swollen at site and very reddened around the area.
9-9-11 woke up this AM with rash on head, chest & extremities: 3-6 mm erythematous papules.
Information has been received from a physician concerning a 20 year old female patient, who one week ago (approximately 02-SEP-2008) was vaccinated with the second dose of GARASIL (Lot # not reported). One week ago (approximately 02-SEP-2008), the patient experienced urinary tract infection after receiving the second dose of GARDASIL. The patient sought medical attention, seen by the physician. There was no product quality complaint. Additional information is expected.
I started feeling nasal congestion, coughing, light fever, headache and nauseated. The symptoms started all together. I started feeling everything it lasted about a week. My fever max was 100., it was two days of fever and headache. The nasal congestion, muscle aches and nausea I had for at least a week. After that week and up to another week I had the muscle pain and fatigued I did still feel a little nauseated. I was not at my best or feeling normal. I was more tired, and short of breath walking up and down my stairs.
This spontaneous report was received from a registered nurse and refers to unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (lot # L015460, expiration date: 20-JUL-2017; lot# M018644, expiration date: September 2017; lot# M022556, expiration date: 26-MAY-2017; lot# M002268, expiration date: 20-SEP-2017) (dose and route of administration were not provided). No adverse effects were reported. Administered doses of vaccines experienced the temperature excursion above 46 degrees Fahrenheit and less than 77 degrees Fahrenheit (the highest temperature: 46.81 degrees Fahrenheit) for 90 minutes. Data logger was involved. There were no previous excursions reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA002226: US-009507513-1702USA002227: US-009507513-1702USA002228.
Abdominal pain.  No bloating, or tenderness.    Calcium, vitamin d and MVI stopped on day seven.  Pain took eight days to resolve.  Had same pain first dose of covid 19 vaccine and while on arimidex.
This spontaneous report as received from a other health professional refers to unspecified patients pf unknown age and gender. On an unknown date patients were vaccinated with M-M-R II lot # M039904 expiration date of 26-SEP-2018 for prophylaxis. On an unknown date, the vaccine was incorrectly storage at a temperature of 11.8 °C. There was no previous temperature excursion. Data logger was involved. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA001111: US-009507513-1708USA001110.
It felt like a weight was on my chest. I had shortness of breath, headache, coughing every now and again, and a sore throat. I tested positive for COVID-19 at home. I talked to my doctor, and he was worried about my chest. So, my doctor told me to go to a walk-in clinic. At the walk-in clinic and they did an EKG and blood work. They sent me to the ER, and they did blood work and CAT scan. All the tests came back fine, and they said I just had a mild case of COVID-19 that had a symptom that could have been a problem.
Dizziness, Headache, Myalgia, hot & cold sweats, shivers Narrative:
Periorbital edema to both eyes that lasted for approximately two days. Child was taken to the emergency room at hospital and the following were administered intramuscularly: Benadryl 25 mg and Decadron 10 mg. In addition, Zyrtec 100 mg was administered orally.
Redness, massive swelling of entire arm from near injection site, down arm to wrist. Pt could not bend arm. Entire arm was warm prescribed oral corticosteroids (prednisome) and Benadryl, 3 days. Pt is Aircrew (flyer) and was grounded and had follow-up with flight surgeon MD Allergist. Swelling was resolved after 3 to 4 days. Event was serious enough to warrant ER visit.
Information has been received from a RN concerning a female pt who was vaccinated with the four doses of measles virus vaccine live + mumps virus vaccine live+ rubella virus vaccine live (second generation) . Subsequently, the pt;s laboratory values indicated a lack of seroconversion. Addtional information has been requested.
She felt dizzy as though the room was spinning. The feeling it was strong enough that she needed to support herself to walk and not to fall. Started about 12 hours post vaccination. Symptoms continued for about 12 hours prior to resolution.
Patient called on 10-14-17 around 11 am with complaints of swollen left arm, approximately 2 inches below the injection site. She said it was swollen, red and itchy. I suggested she take 650 mg of TYLENOL every 6 hours, apply a cold compress for 15 minutes 4 times a day, and take 25-50 mg of BENADRYL 3-4 times a day to reduce the itching reaction. I spoke with her at 3:15 pm on 10-16-17 and she said she has been following these instructions and it is getting better but not quite resolved and that she will continue these recommendations. She said she did not feel like she needed to contact her doctor at this time. She did mention on 10-16-17 that it had been swollen the size of a baby grapefruit when she called on 10-14-17 but she had not mentioned that initially. She said it is just slightly red and swollen now.
Severe swelling of arm on injection site, fever, headache, achy. On 08/21/2015, I went to walk-in clinic and was treated for cellulitis.
Information has been received from a physician concerning a 75 year old female with no diabetes or any underlying disease who "over two years ago" in approximately 2008 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # not reported). Subsequently the patient developed prominent zoster on her trunk. At the time on the report the patient's outcome was unknown. Additional information has been requested.
had Covid; had Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A 64-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "immunocompromised" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2023, outcome "unknown" and all described as "had Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jul2023) Positive, notes: her husband they had covid in Jul. Clinical course: Caller said she and her husband they had covid in Jul and wants to know when they will be able to get the booster vaccine. The caller reported that she and her husband both had Covid in Jul2023 and they read you have to wait 3 months after Covid to get another booster and wanted to check if that was correct. They have had two initial vaccines, 3 boosters and one of those was the bivalent vaccine. She stated they had the Pfizer Covid vaccines- the two initial vaccinations and 3 boosters. The last booster being Oct of last year and that one was bivalent. They have only received one bivalent vaccine, all of them Pfizer Covid vaccines. They had Covid in Jul2023. She stated they have home tests and they tested positive but since they recovered, or she assumed they recovered. Her husband is 64 years old and immunocompromised- He has an upcoming appointment with his doctor and they will see if he is eligible for another booster.      The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300278629 similar report from same reporter/diff patient;
24 hours after vaccination, child reported arm pain at site of vaccine. Mother observed shoulder to elbow redness, warmth and swelling. Given BENADRYL x 2 doses with relief of all sx within 48 hours.
Patient was in the "hall" after receiving flu and HPV vaccines. She fainted and her head hit the wall. She awakened after a few seconds. She was able to ambulate to an exam room with help. She was placed in a supine position with her legs elevated. She was oriented x3. After eating a cracker with peanut butter and a popsicle she set up and was not dizzy walked to car independently.
Injection site is developed large hive with redness anf hot to touch.  there is no tenderness. no fever, no SOB. Normal mental status.  the Hive was developed in 48 hourse after injection.
06/25/2022   I caught Covid. Severe cough. 4 days. I also took PAXLOVID ( Renal lower dose)
suspected vaccination failure/had the shingles shot / it worked only for three years; it worked only for three years; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a 50-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included immune system disorder (had has lower immune system for arthritis) and arthritis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, 3 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient self-reported this case. The patient was in a biologic which lower immune system for arthritis. The patient had the shingles shot and it worked for only 3 years. The patient asked if the two shots of Shingrix work better the second time. The patient stated that the website said that 91 percent so might be the patient was in 9 percent, they were talking about. This case was considered as suspected vaccination failure as details regarding the laboratory test confirmation were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Health dept. provided Tdap to rising 6 graders in school setting. Received vaccine (Tdap) rt. arm - walked to nearby desk - Fainted to floor. 3 RN's present.